Reliable measurements of brain atrophy in individual patients with multiple sclerosis

INTRODUCTION: As neurodegeneration is recognized as a major contributor to disability in multiple sclerosis (MS), brain atrophy quantification could have a high added value in clinical practice to assess treatment efficacy and disease progression, provided that it has a sufficiently low measurement...

Descripción completa

Detalles Bibliográficos
Autores principales: Smeets, Dirk, Ribbens, Annemie, Sima, Diana M., Cambron, Melissa, Horakova, Dana, Jain, Saurabh, Maertens, Anke, Van Vlierberghe, Eline, Terzopoulos, Vasilis, Van Binst, Anne‐Marie, Vaneckova, Manuela, Krasensky, Jan, Uher, Tomas, Seidl, Zdenek, De Keyser, Jacques, Nagels, Guy, De Mey, Johan, Havrdova, Eva, Van Hecke, Wim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Methods
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036437/
https://www.ncbi.nlm.nih.gov/pubmed/27688944
http://dx.doi.org/10.1002/brb3.518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036437/
https://www.ncbi.nlm.nih.gov/pubmed/27688944
http://dx.doi.org/10.1002/brb3.518

Ejemplares similares